Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 113   

Articles published

JNJ 102.07 -1.15 (-1.11%)
price chart
Johnson & Johnson Announces Formation of New Health and Wellness Platform ...
NEW BRUNSWICK, N.J., Feb. 26, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the formation of a new health and wellness platform that leverages the breadth of capabilities across its businesses.
Johnson & Johnson (JNJ) Forms New Health, Wellness Program  StreetInsider.com
Market Update (NYSE:JNJ): Johnson & Johnson Announces Formation of New ...  Jutia Group
Johnson & Johnson Investors Should Welcome The Acquisition Of Pharmacyclics
Pharmacyclics' (NASDAQ:PCYC) stock has been on a tear the last few months, with the latest jump being a near 17% intraday gain after Bloomberg reported the company is mulling a potential sale.
Cramer: Pharmacyclics-Johnson & Johnson Deal Unlikely at This Price  TheStreet.com
Pharmacyclics, Inc. Said To Consider A Sale; Johnson & Johnson, Novartis ...  Bidness ETC
Boston Scientific will pay Johnson & Johnson $600M to end lawsuit over 2006 ...
NEW YORK - Boston Scientific will pay $600 million to settle with drugmaker Johnson & Johnson over the medical device maker's $27 billion acquisition of Guidant Corp.
Boston Scientific (BSX) Stock Higher Today After Johnson & Johnson Suit ...  TheStreet.com
Boston Scientific settles $7.2B lawsuit brought by Johnson & Johnson for $600M
Johnson & Johnson (NYSE: JNJ) claimed in the lawsuit that Guidant, for which Boston Scientific paid $27 billion, broke the terms of an earlier contract to be acquired by J&J by providing information to BSX.
Boston Scientific settles suit by Johnson & Johnson  Worcester Business Journal
How To Trade Johnson & Johnson, Coca-Cola, Nike And Travelers
Investors looking to buy Johnson & Johnson should enter a �good 'til canceled� limit order to buy weakness to an annual value level at $87.14.
Judge Orders Johnson & Johnson Subsidiary to Pay $136M for Deceptive ...
A Johnson & Johnson subsidiary should pay the state $136 million over deceptive drug marketing of an anti-psychotic drug, South Carolina's highest court ruled this week, upholding penalties against the company but reducing the amount.
Cardinal Health To Acquire Johnson & Johnson's Cordis Business (CAH, JNJ)
Before Monday's opening bell, Cardinal Health (CAH ) announced that it has agreed to buy Johnson & Johnson's (JNJ ) Cordis interventional medical devices business for $1.944 billion.
Johnson & Johnson Loses Risperdal Jury Trial After Young Man Grew 46 DD ...
A Philadelphia jury said Tuesday that drugmaker Johnson & Johnson should pay $2.5 million to a 20-year-old man with autism from Alabama - who developed size 46 DD breasts as a young teenager - because the company failed to adequately warn of ...
Autistic man wins $2.5M after meds gave him 46DD breasts  KCCI Des Moines
Johnson & Johnson Given Buy Rating at Wells Fargo & Co. (JNJ)
Shares of Johnson & Johnson (NYSE:JNJ) traded up 0.69% during mid-day trading on Monday, hitting $103.22. 7,265,290 shares of the company's stock traded hands.
Investor Insights on Johnson & Johnson (NYSE:JNJ)  Markets Wired
Healthcare Stocks : Johnson & Johnson (NYSE:JNJ), Medtronic plc (NYSE ...  eMarketsDaily
Cardinal Health To Acquire Johnson & Johnson's Cordis Business - Quick Facts
(RTTNews.com) - Cardinal Health ( CAH ) announced plans to acquire Johnson & Johnson'sCordis business, a global manufacturer of cardiology and endovascular devices, for $1.944 billion in cash, or approximately $1.594 billion, net of the present value ...